BCG helps biopharma companies fulfill their mission of delivering life-changing medicines and therapies, and take advantage of new technologies—including digital, data, and advanced analytics—in order to unlock innovation and bring new medicines to market faster.

Biopharma companies turn inspiration into innovation, discovering new medicines that improve and save lives—and they’re in the midst of transforming how they do it. The global pandemic has pushed digital, data, and analytics to the forefront of the industry, shortening the time it takes to develop new medicines and bring them to patients. Next-generation capabilities are driving more rapid and effective manufacturing and supply chains. They’re also enabling the swift redesign of networks, the creation of new commercial models and patient-engagement ventures, and the pursuit of new value-creation opportunities through M&A.

How We Enable Biopharma Excellence

We support clients in every aspect of biopharma excellence, including strategy, operations, and transformation. Increasingly, this means focusing on digital, data, and analytics, which are driving change throughout the biopharma value chain. BCG provides biopharma sector companies with custom solutions drawn from our deep knowledge of both digital and the industry. Our experts include an extensive group of PhDs and advanced-degree holders in biopharma industry-related disciplines with significant pre-consulting industry experience.

R&D Innovation

Next-Generation Commercial Models

Excellence in Operations

Corporate Finance, Strategy, and M&A

Digital and Analytics Capabilities

Our biopharma consultants work closely BCG’s specialty businesses on specific value-chain priorities, including digital supply chain, next-generation sales, personalization, and digital marketing. With our guidance, companies can rapidly scale new capabilities and ways of working through agile at scale, data and digital platforms, and our Build-Operate-Transfer approach. We collaborate with GAMMA on projects that require applied data science and advanced analytics, and with BCG Digital Ventures to launch new businesses.

Zoetis’s CEO and Chief Digital Officer Talk Transformation

How technology, data, and analytics are helping the company build on its history as an innovator in animal health.

Bayer's Journey to Operational Excellence

The company identified data-driven solutions that not only boost efficiency but can be converted into systemic change and scaled throughout the global business.

Pfizer’s Formula for Agile in Pharma

Jim Riley reveals how the company applied agile principles and frameworks within its highly regulated and structured environment, breaking down silos and significantly accelerating product delivery.

How AI Helped Get the Right Treatment to Cancer Patients

To help an oncology center improve treatment, BCG GAMMA developed an advanced analytics solution and innovative digital tool by using AI techniques, machine learning algorithms, and marketing strategies.

Our Proprietary Biopharma Solutions

Integrated into our biopharma industry solutions are an array of proprietary tools, including benchmarks, databases, and other knowledge assets. Some highlights:

Our Insights on the Biopharma Industry

Gene Editing Gets Ready for the Spotlight | Rectangle

Gene Editing Gets Ready for the Spotlight

Pharma has invested billions in cell and gene therapies. Gene editing is making a case for more of this funding, but companies need to understand what they’re investing in and why.

Meet Our Biopharma Consulting Experts

protected by reCaptcha

Shape the Future of Health Care: The latest insights on the future of the industry.